# Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

> **NCT05647915** · PHASE4 · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 337 (actual)

## Conditions studied

- Obesity
- Obesity, Abdominal
- NAFLD

## Interventions

- **DRUG:** Berberine plus lifestyle intervention
- **BEHAVIORAL:** Placebo plus lifestyle intervention

## Key facts

- **NCT ID:** NCT05647915
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2024-08-09
- **Final completion:** 2024-08-09
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647915, "Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05647915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*